Provided by Tiger Trade Technology Pte. Ltd.

Gilead Sciences

144.99
+0.60000.42%
Post-market: 144.990.00000.00%19:49 EDT
Volume:4.38M
Turnover:636.23M
Market Cap:179.89B
PE:21.38
High:148.22
Open:146.85
Low:144.20
Close:144.39
52wk High:157.29
52wk Low:93.37
Shares:1.24B
Float Shares:1.24B
Volume Ratio:0.79
T/O Rate:0.35%
Dividend:3.16
Dividend Rate:2.18%
EPS(TTM):6.78
EPS(LYR):6.78
ROE:40.66%
ROA:12.52%
PB:7.92
PE(LYR):21.38

Loading ...

Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum And Mixed Fair Value Signals

Simply Wall St.
·
Mar 12

Where Has Wall Street's Institutional Capital Flowed? Bank of America Report Points to AI, with Palantir and Broadcom Leading Inflows

Stock News
·
Mar 12

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 11

Gilead Sciences Initiated at Buy by Jefferies

Dow Jones
·
Mar 10

Gilead : Jefferies Initiates Coverage With Buy Rating; Price Target $180

THOMSON REUTERS
·
Mar 10

U.S. RESEARCH ROUNDUP-Adobe, Caseys General Stores, FedEx

Reuters
·
Mar 10

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 10

IDEAYA Biosciences reports first patient enrolled in Phase 1 IDE892 trial for MTAP-deleted solid tumors

Reuters
·
Mar 09

Gilead Sciences' HIV Drug Eyed for Local Production by South Africa

MT Newswires Live
·
Mar 06

Gilead Sciences Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Mar 06

Gilead Sciences to Buy Arcellx for $115 a Share Plus $5 CVR

Reuters
·
Mar 06

Tango Therapeutics posts FY 2025 collaboration revenue of USD 62.4 million +108.2%

Reuters
·
Mar 05

South Africa seeks local production of Gilead's HIV prevention drug

Reuters
·
Mar 05

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Mar 04

Gilead Exec Says Anito-Cel Could Address an "up to $20 Billion" Multiple Myeloma Opportunity When Considering Use in First-Line Treatment- TD Cowen Conference

THOMSON REUTERS
·
Mar 04

Gilead Exec Says Anito-Cel Is Expected to Launch at the End of This Year - TD Cowen Conference

THOMSON REUTERS
·
Mar 04

Gilead Sciences CEO Daniel Patrick O'Day Disposes of Common Shares

Reuters
·
Mar 03

BRIEF-Gilead Foundation Awards $12 Million To Empower Community Health Workers And Expand Hiv Prevention Initiatives Across 14 States And The District Of Columbia

Reuters
·
Mar 02

Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand Hiv Prevention Initiatives Across 14 States and the District of Columbia

THOMSON REUTERS
·
Mar 02

CORRECTED-Israel's Compugen Q4 revenue beats on rilvegostomig royalties

Reuters
·
Mar 02